Template:Company

What They Do edit

Irish MedTech developing a new minimally invasive treatment for benign prostatic hyperplasia (BPH). Largest Irish MedTech raise in 2025.

Funding edit

Valuation: ~€200M+ (est.) €68.6M (2025)

See Also edit